Adhesion of human neuroblasts to HIV-1 tat

P. Cornaglia-Ferraris, A. De Maria, C. Cirillo, A. Cara, G. Alessandri

Research output: Contribution to journalArticle

Abstract

Several neuropathologic findings in infants and children with human immunodeficiency virus type-1 (HIV-1) infection are different from those observed in adults, probably related to the fact that the retroviral infection occurs in the setting of neurodevelopment. This report describes the interaction and biologic activity of tat, the HIV-1 frarci-activating protein on human neuroblasts. Two human neuroblastoma cell lines, LAN-5 and GI-CA-N, have been studied for their capability to adhere to tat (full recombinant protein) and to two different peptide residues of it. Both cells adhere to tat and tat46-60 basic domain, although not to far65-80 residue, which contains the RGD (arginine-glycine-aspartic acid) motif. Adhesion to collagen I was inhibited by preincubating GI-CA-N cells with fai,46-60 although not with tat,65-80 indicating the capability of the basic residue to interfere with collagen I-induced cellular adhesion. The expression of 200-kD neurofilaments induced by collagen I was not induced by tat,46-60 indicating that neural differentiation along the same pathway is not mimicked by this peptide. Neuroblast cell proliferation was not affected by adhesion to tat46-60 nor to tat.65-80 GI-CA-N cells are not permissive to HIV-1 infection. However, proviral DNA was documented in the cell lysate for 14 consecutive in vitro passages, whereas HIV-1 transcription was never detectable. This would exclude the possibility that tat would be transduced by these cells. GI-CA-N stained negative for CD4, although positive for Gal-C, which may explain HIV-1 entry. Results show that immature human neural cells interact with tat protein and/or its basic residue in vitro. A mechanism similar to that herein described would possibly be active in vivo, which may help in clarifying the pathogenic mechanisms of neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-1.

Original languageEnglish
Pages (from-to)792-796
Number of pages5
JournalPediatric Research
Volume38
Issue number5
Publication statusPublished - 1995

Fingerprint

HIV-1
Collagen
Virus Diseases
Local Area Networks
tat Gene Products
Virus Internalization
Peptides
Neurologic Manifestations
Neuroblastoma
Recombinant Proteins
Aspartic Acid
Glycine
Arginine
Cell Proliferation
Cell Line
DNA
Infection
Proteins
In Vitro Techniques

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Cornaglia-Ferraris, P., De Maria, A., Cirillo, C., Cara, A., & Alessandri, G. (1995). Adhesion of human neuroblasts to HIV-1 tat. Pediatric Research, 38(5), 792-796.

Adhesion of human neuroblasts to HIV-1 tat. / Cornaglia-Ferraris, P.; De Maria, A.; Cirillo, C.; Cara, A.; Alessandri, G.

In: Pediatric Research, Vol. 38, No. 5, 1995, p. 792-796.

Research output: Contribution to journalArticle

Cornaglia-Ferraris, P, De Maria, A, Cirillo, C, Cara, A & Alessandri, G 1995, 'Adhesion of human neuroblasts to HIV-1 tat', Pediatric Research, vol. 38, no. 5, pp. 792-796.
Cornaglia-Ferraris P, De Maria A, Cirillo C, Cara A, Alessandri G. Adhesion of human neuroblasts to HIV-1 tat. Pediatric Research. 1995;38(5):792-796.
Cornaglia-Ferraris, P. ; De Maria, A. ; Cirillo, C. ; Cara, A. ; Alessandri, G. / Adhesion of human neuroblasts to HIV-1 tat. In: Pediatric Research. 1995 ; Vol. 38, No. 5. pp. 792-796.
@article{a908a26d8ce94451a14d4772273d9af6,
title = "Adhesion of human neuroblasts to HIV-1 tat",
abstract = "Several neuropathologic findings in infants and children with human immunodeficiency virus type-1 (HIV-1) infection are different from those observed in adults, probably related to the fact that the retroviral infection occurs in the setting of neurodevelopment. This report describes the interaction and biologic activity of tat, the HIV-1 frarci-activating protein on human neuroblasts. Two human neuroblastoma cell lines, LAN-5 and GI-CA-N, have been studied for their capability to adhere to tat (full recombinant protein) and to two different peptide residues of it. Both cells adhere to tat and tat46-60 basic domain, although not to far65-80 residue, which contains the RGD (arginine-glycine-aspartic acid) motif. Adhesion to collagen I was inhibited by preincubating GI-CA-N cells with fai,46-60 although not with tat,65-80 indicating the capability of the basic residue to interfere with collagen I-induced cellular adhesion. The expression of 200-kD neurofilaments induced by collagen I was not induced by tat,46-60 indicating that neural differentiation along the same pathway is not mimicked by this peptide. Neuroblast cell proliferation was not affected by adhesion to tat46-60 nor to tat.65-80 GI-CA-N cells are not permissive to HIV-1 infection. However, proviral DNA was documented in the cell lysate for 14 consecutive in vitro passages, whereas HIV-1 transcription was never detectable. This would exclude the possibility that tat would be transduced by these cells. GI-CA-N stained negative for CD4, although positive for Gal-C, which may explain HIV-1 entry. Results show that immature human neural cells interact with tat protein and/or its basic residue in vitro. A mechanism similar to that herein described would possibly be active in vivo, which may help in clarifying the pathogenic mechanisms of neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-1.",
author = "P. Cornaglia-Ferraris and {De Maria}, A. and C. Cirillo and A. Cara and G. Alessandri",
year = "1995",
language = "English",
volume = "38",
pages = "792--796",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Adhesion of human neuroblasts to HIV-1 tat

AU - Cornaglia-Ferraris, P.

AU - De Maria, A.

AU - Cirillo, C.

AU - Cara, A.

AU - Alessandri, G.

PY - 1995

Y1 - 1995

N2 - Several neuropathologic findings in infants and children with human immunodeficiency virus type-1 (HIV-1) infection are different from those observed in adults, probably related to the fact that the retroviral infection occurs in the setting of neurodevelopment. This report describes the interaction and biologic activity of tat, the HIV-1 frarci-activating protein on human neuroblasts. Two human neuroblastoma cell lines, LAN-5 and GI-CA-N, have been studied for their capability to adhere to tat (full recombinant protein) and to two different peptide residues of it. Both cells adhere to tat and tat46-60 basic domain, although not to far65-80 residue, which contains the RGD (arginine-glycine-aspartic acid) motif. Adhesion to collagen I was inhibited by preincubating GI-CA-N cells with fai,46-60 although not with tat,65-80 indicating the capability of the basic residue to interfere with collagen I-induced cellular adhesion. The expression of 200-kD neurofilaments induced by collagen I was not induced by tat,46-60 indicating that neural differentiation along the same pathway is not mimicked by this peptide. Neuroblast cell proliferation was not affected by adhesion to tat46-60 nor to tat.65-80 GI-CA-N cells are not permissive to HIV-1 infection. However, proviral DNA was documented in the cell lysate for 14 consecutive in vitro passages, whereas HIV-1 transcription was never detectable. This would exclude the possibility that tat would be transduced by these cells. GI-CA-N stained negative for CD4, although positive for Gal-C, which may explain HIV-1 entry. Results show that immature human neural cells interact with tat protein and/or its basic residue in vitro. A mechanism similar to that herein described would possibly be active in vivo, which may help in clarifying the pathogenic mechanisms of neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-1.

AB - Several neuropathologic findings in infants and children with human immunodeficiency virus type-1 (HIV-1) infection are different from those observed in adults, probably related to the fact that the retroviral infection occurs in the setting of neurodevelopment. This report describes the interaction and biologic activity of tat, the HIV-1 frarci-activating protein on human neuroblasts. Two human neuroblastoma cell lines, LAN-5 and GI-CA-N, have been studied for their capability to adhere to tat (full recombinant protein) and to two different peptide residues of it. Both cells adhere to tat and tat46-60 basic domain, although not to far65-80 residue, which contains the RGD (arginine-glycine-aspartic acid) motif. Adhesion to collagen I was inhibited by preincubating GI-CA-N cells with fai,46-60 although not with tat,65-80 indicating the capability of the basic residue to interfere with collagen I-induced cellular adhesion. The expression of 200-kD neurofilaments induced by collagen I was not induced by tat,46-60 indicating that neural differentiation along the same pathway is not mimicked by this peptide. Neuroblast cell proliferation was not affected by adhesion to tat46-60 nor to tat.65-80 GI-CA-N cells are not permissive to HIV-1 infection. However, proviral DNA was documented in the cell lysate for 14 consecutive in vitro passages, whereas HIV-1 transcription was never detectable. This would exclude the possibility that tat would be transduced by these cells. GI-CA-N stained negative for CD4, although positive for Gal-C, which may explain HIV-1 entry. Results show that immature human neural cells interact with tat protein and/or its basic residue in vitro. A mechanism similar to that herein described would possibly be active in vivo, which may help in clarifying the pathogenic mechanisms of neurologic dysfunction and destruction of the CNS observed in infants infected with HIV-1.

UR - http://www.scopus.com/inward/record.url?scp=0028821880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028821880&partnerID=8YFLogxK

M3 - Article

C2 - 8552450

AN - SCOPUS:0028821880

VL - 38

SP - 792

EP - 796

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5

ER -